Up Next

ki-logo-white
Market-Based Solutions to Vital Economic Issues

SEARCH

ki-logo-white
Market-Based Solutions to Vital Economic Issues
Event
Nov 13, 2020

Virtual Event: Dean’s Speaker Series — Brian Caveney

Please join us for an exclusive conversation with LabCorp Executive Vice President & President of Diagnostics Brian Caveney on Friday, Nov. 13. This virtual fireside chat is part of the Dean’s Speaker Series, hosted by Kenan-Flagler Business School Dean Doug Shackelford. The discussion will be lead by Brad Staats, Associate Dean of MBA Programs, Professor of Operations, Sarah Graham Kenan Scholar & Faculty Director of the Center for the Business of Health.

This event is a conference keynote and only available to those attending the 2020 Business of Healthcare – Better Together: Improving Interconnectivity in the Healthcare Ecosystem.

Dr. Caveney holds an MD from the West Virginia University School of Medicine, a JD from the West Virginia University College of Law and an MPH in health policy and administration from the University of North Carolina at Chapel Hill. He completed his residency at Duke University Medical Center and is board-certified in preventive medicine, with a specialty in occupational and environmental medicine. He is the past president of the Southeastern Atlantic College of Occupational and Environmental Medicine and continues to hold an active law license in North Carolina.

Dr. Caveney came to LabCorp after serving as chief medical officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC) since 2011. Dr. Caveney also served as chief clinical officer of Mosaic Health Solutions, a wholly owned subsidiary of Blue Cross NC for strategic investments in diversified health solutions businesses. Prior to joining Blue Cross NC, Dr. Caveney was a practicing physician and assistant professor at Duke University Medical Center and also provided consulting services for several companies in the Research Triangle Park region.

At LabCorp, Dr. Caveney has broad responsibility for medical and scientific strategy, including serving as primary medical representative for the company externally, defining global standards for medical and scientific activities across LabCorp’s Diagnostics and Drug Development businesses, and enhancing a culture of medical and scientific excellence.

For more information, contact:

Emily Schumacher, Events Coordinator Emily_Schumacher@kenan-flagler.unc.edu


Nov
13
2020
12:00 PM

You may also be interested in: